These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 22156853

  • 1. Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
    Butt AA, Kanwal F.
    Clin Infect Dis; 2012 Jan 01; 54(1):96-104. PubMed ID: 22156853
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions.
    Seden K, Back D.
    Curr Opin HIV AIDS; 2011 Nov 01; 6(6):514-26. PubMed ID: 22001895
    [Abstract] [Full Text] [Related]

  • 4. Future perspectives: towards interferon-free regimens for HCV.
    Gane E.
    Antivir Ther; 2012 Nov 01; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [Abstract] [Full Text] [Related]

  • 5. Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?
    Pascale A, Serfaty L.
    J Hepatol; 2013 Feb 01; 58(2):391-4. PubMed ID: 23063419
    [Abstract] [Full Text] [Related]

  • 6. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ, Matthews GV, Rockstroh J.
    Curr Opin HIV AIDS; 2011 Nov 01; 6(6):508-13. PubMed ID: 21897228
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
    Marks KM, Jacobson IM.
    Antivir Ther; 2012 Nov 01; 17(6 Pt B):1119-31. PubMed ID: 23188750
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
    Belperio PS, Hwang EW, Thomas IC, Mole LA, Cheung RC, Backus LI.
    Clin Gastroenterol Hepatol; 2013 Aug 01; 11(8):1021-7. PubMed ID: 23524130
    [Abstract] [Full Text] [Related]

  • 11. Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
    Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J.
    Antimicrob Agents Chemother; 2014 Sep 01; 58(9):5332-41. PubMed ID: 24982076
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.
    Jacobson IM, Pawlotsky JM, Afdhal NH, Dusheiko GM, Forns X, Jensen DM, Poordad F, Schulz J.
    J Viral Hepat; 2012 May 01; 19 Suppl 2():1-26. PubMed ID: 22404758
    [Abstract] [Full Text] [Related]

  • 14. Anemia management in patients with chronic viral hepatitis C.
    Hynicka LM, Heil EL.
    Ann Pharmacother; 2013 Feb 01; 47(2):228-36. PubMed ID: 23386076
    [Abstract] [Full Text] [Related]

  • 15. Direct-acting antiviral (DAA) actions in treatment-naïve patients.
    Hézode C.
    Clin Res Hepatol Gastroenterol; 2011 Dec 01; 35 Suppl 2():S52-8. PubMed ID: 22248695
    [Abstract] [Full Text] [Related]

  • 16. [Hepatitis C virus: 25 years-old, the end?].
    Pol S.
    Med Sci (Paris); 2013 Nov 01; 29(11):998-1003. PubMed ID: 24280503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.
    Trembling PM, Tanwar S, Dusheiko GM.
    Expert Rev Anti Infect Ther; 2012 Mar 01; 10(3):269-79. PubMed ID: 22397560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.